I try to be as transparent as possible about my conflicts of interests. If these conflicts cause an issue with the work or working relationship between me and a lab member, I want people to have those conversations with me early. The Dean of the UCSF School of Pharmacy would be a good person to talk to if you don’t feel comfortable talking to me about it directly.
Appointments:
- Professor and Chair, Department of Bioengineering and Therapeutic Sciences, Schools of Pharmacy and Medicine, University of California San Francisco
- Faculty Scientist,Molecular Biophysics and Integrated Bioimaging, Lawrence Berkeley National Laboratory
- Associate Director and Member, Quantitative Biosciences Institute, University of California San Francisco
- Co-director, Bakar Computational Biomedicine Initiative, UCSF and UC Berkeley
- Governing Board Member, OpenADMET
- Past: Board Member, ASAPbio
Equity (including spouse):
Consulting/speaker fees/travel:
- Relay Therapeutics
- Profluent Bio
- Vilya Therapeutics
- Monimoi Therapeutics
- Flagship Pioneering
- IsingTx
- Past: Amgen, Octant, Merck, Olema, RADD Pharmaceuticals, RA Capital, MoMa Therapeutics, Novartis, Arcadia Science, Genentech, Revolution Medicines, Third Rock Ventures, Calico, GSK, Schrödinger, CCG, OpenEye, Roche, AstraZeneca, Global Blood Therapeutics
Sponsored and Collaborative Research:
- Through our work in OpenADMET, we collaborate with Octant (funded by ARPA-H, the Astera Institute, and the Gates Foundation) and Schrödinger (funded by the Gates Foundation). None of this work is proprietary and we make all data and code available to the public.
- Past: Relay Therapeutics, Salesforce, Eli Lilly and Company, JSR, Asahi Kasei
I also am the head of the participating research team of beamline 8.3.1. at the Advanced Light Source. Many companies have used that beamline or have sponsored research and development activities by the beamline scientists, including: Achira, Plexxikon, Relay Therapeutics, Eli Lilly and Company, and Global Blood Therapeutics.